August 22, 2005
by M.R. Subramani,
The Hindu
Business Line via
Checkbiotech
The bio-technology industry says
it has turned its focus on drought-resistant and health
providing genetically modified (GM) crops. But world-wide data
shows that the pipeline of GM crops research is drying up.
In the US, which is the global
leader insofar as GM crop research is concerned, not a single
petition has been filed for field trials this year. And
statistics available from other nations show that the number
decline in field trials of GM crops began in 2003.
According to a presentation by Dr Greg Jaffe, Director, Centre
for Science in Public Interest, at a recent biotechnology
conference in the US, 75 per cent of the GM crops that are in
the trials state would be completing the process of getting
approval from the US Food and Drug Administration (FDA).
Again, only three companies - Monsanto, DuPont and Syngenta -
have been actively carrying out trials in the area of GM
organisms.
According to the US Department of Agriculture, there has been a
slide since 1995 when 15 petitions were filed. The lowest number
of applications - five - were filed in 2002 and things improved
marginally during 2003 and 2004.
In Canada, confined research field trials of GM crops have
declined from 178 in 2000 to 64 in 2004. In the EU,
environmental release of GM crops has slid from 264 in 1997 to
68 in 2004. In both these places, there was a rise in activity
during 2003.
According to Dr Jaffe, there were only 15 consultations for GM
crops between 2000 and 2004 in the US.
"GM crop trials have basically been curtailed to cotton, corn,
soyabean and canola. And these have been for only herbicide and
insect resistance," he says.
One reason for the loss of interest in carrying out research in
GM crops could be the length of time taken to review the
petitions by the authorities, especially in the US.
During 1995-99, the FDA took six to months to review a petition
but between 2000 and 2004 the time taken was 13-14 months.
"For instance, the Roundup Ready got the FDA approval in six
months but the Roundup Ready wheat took 26 months," Dr Jaffe
says.
In another instance, it took 14 months (filed in April 2004;
approved in June 2005) for the US authorities to approve
alfalfa, a cattle fodder. At the same time, a
glyphosate-tolerant corn got approval in roughly eight months
(filed in January 2000; approved in September 2000).
Incidentally, alfalfa is the only crop that has been approved by
the US authorities this year.
According to agriculture experts, the firms intending to bring
out new GM crops are concerned about the time taken to get
approval for a new strain and the high costs involved in it.
"Maybe, a change in the regulatory system can lead to renewed
interest in research of GM crops. Also, a review is needed to
cut costs since funding for research is limited," an expert
said.
However, at the laboratory level, work is on in a few fields
with at least two research works related to India. One is rice
rich in folic acid to rectify malnutrition problems and the
other is a groundnut variety that is immune to the tobacco
streak virus.
Among the others are apples, bananas and wheat. DuPont is
developing a glyphosate resistant crop. Monsanto is developing
apples that have in-built resistance against codling moth. There
are at least seven varieties of GM corn in the pipeline,
including ones that nutritionally enhances, three varieties of
corn and two strains of soyabean.
Copyright © 2005,
The Hindu Business Line |